How to use the speech recognition tool?
Gene therapy study on choroideremia : to assess the safety and tolerability of the AAV.REP1 vector, administered at two different doses to the retina in patients with a diagnosis of choroideremia.
Status of the trial: Completed
Orphan Drug Recognition: Yes
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators